Matches in SemOpenAlex for { <https://semopenalex.org/work/W3139129667> ?p ?o ?g. }
- W3139129667 endingPage "4108" @default.
- W3139129667 startingPage "4089" @default.
- W3139129667 abstract "Neuropeptide S modulates important neurobiological functions including locomotion, anxiety, and drug abuse through interaction with its G protein-coupled receptor known as neuropeptide S receptor (NPSR). NPSR antagonists are potentially useful for the treatment of substance abuse disorders against which there is an urgent need for new effective therapeutic approaches. Potent NPSR antagonists in vitro have been discovered which, however, require further optimization of their in vivo pharmacological profile. This work describes a new series of NPSR antagonists of the oxazolo[3,4-a]pyrazine class. The guanidine derivative 16 exhibited nanomolar activity in vitro and 5-fold improved potency in vivo compared to SHA-68, a reference pharmacological tool in this field. Compound 16 can be considered a new tool for research studies on the translational potential of the NPSergic system. An in-depth molecular modeling investigation was also performed to gain new insights into the observed structure–activity relationships and provide an updated model of ligand/NPSR interactions." @default.
- W3139129667 created "2021-03-29" @default.
- W3139129667 creator A5001745874 @default.
- W3139129667 creator A5009870571 @default.
- W3139129667 creator A5014036986 @default.
- W3139129667 creator A5014585825 @default.
- W3139129667 creator A5024858680 @default.
- W3139129667 creator A5027310941 @default.
- W3139129667 creator A5028341235 @default.
- W3139129667 creator A5035158413 @default.
- W3139129667 creator A5036528092 @default.
- W3139129667 creator A5036928003 @default.
- W3139129667 creator A5040603165 @default.
- W3139129667 creator A5043198262 @default.
- W3139129667 creator A5064020987 @default.
- W3139129667 creator A5068576727 @default.
- W3139129667 creator A5084049428 @default.
- W3139129667 creator A5090301094 @default.
- W3139129667 date "2021-03-18" @default.
- W3139129667 modified "2023-10-18" @default.
- W3139129667 title "Structure–Activity Relationship Studies on Oxazolo[3,4-<i>a</i>]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent <i>In Vivo</i> Activity" @default.
- W3139129667 cites W1196153924 @default.
- W3139129667 cites W1484197568 @default.
- W3139129667 cites W1593555249 @default.
- W3139129667 cites W1786092055 @default.
- W3139129667 cites W1966913245 @default.
- W3139129667 cites W1967544385 @default.
- W3139129667 cites W1972758026 @default.
- W3139129667 cites W1975932489 @default.
- W3139129667 cites W1979728801 @default.
- W3139129667 cites W1982670342 @default.
- W3139129667 cites W1988498352 @default.
- W3139129667 cites W1990265358 @default.
- W3139129667 cites W1991794210 @default.
- W3139129667 cites W1994800236 @default.
- W3139129667 cites W1998478270 @default.
- W3139129667 cites W2005174659 @default.
- W3139129667 cites W2011664501 @default.
- W3139129667 cites W2012775933 @default.
- W3139129667 cites W2013745847 @default.
- W3139129667 cites W2014055152 @default.
- W3139129667 cites W2017835622 @default.
- W3139129667 cites W2020116343 @default.
- W3139129667 cites W2026030437 @default.
- W3139129667 cites W2028444619 @default.
- W3139129667 cites W2035369931 @default.
- W3139129667 cites W2040487636 @default.
- W3139129667 cites W2041638382 @default.
- W3139129667 cites W2046126967 @default.
- W3139129667 cites W2053088166 @default.
- W3139129667 cites W2060079863 @default.
- W3139129667 cites W2060478956 @default.
- W3139129667 cites W2061535870 @default.
- W3139129667 cites W2063641313 @default.
- W3139129667 cites W2080485913 @default.
- W3139129667 cites W2086022638 @default.
- W3139129667 cites W2090951839 @default.
- W3139129667 cites W2093270220 @default.
- W3139129667 cites W2097365951 @default.
- W3139129667 cites W2097559461 @default.
- W3139129667 cites W2110177837 @default.
- W3139129667 cites W2121361277 @default.
- W3139129667 cites W2132629607 @default.
- W3139129667 cites W2138305674 @default.
- W3139129667 cites W2138522158 @default.
- W3139129667 cites W2145233873 @default.
- W3139129667 cites W2150981663 @default.
- W3139129667 cites W2152853006 @default.
- W3139129667 cites W2153228625 @default.
- W3139129667 cites W2158197796 @default.
- W3139129667 cites W2183358035 @default.
- W3139129667 cites W2222589778 @default.
- W3139129667 cites W2294051689 @default.
- W3139129667 cites W2542707307 @default.
- W3139129667 cites W2748712988 @default.
- W3139129667 cites W2792136687 @default.
- W3139129667 cites W2802089023 @default.
- W3139129667 cites W2806957894 @default.
- W3139129667 cites W2952033922 @default.
- W3139129667 cites W2984255851 @default.
- W3139129667 cites W333260301 @default.
- W3139129667 cites W4234946072 @default.
- W3139129667 cites W4252536872 @default.
- W3139129667 cites W953610276 @default.
- W3139129667 doi "https://doi.org/10.1021/acs.jmedchem.0c02223" @default.
- W3139129667 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8041306" @default.
- W3139129667 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33733768" @default.
- W3139129667 hasPublicationYear "2021" @default.
- W3139129667 type Work @default.
- W3139129667 sameAs 3139129667 @default.
- W3139129667 citedByCount "5" @default.
- W3139129667 countsByYear W31391296672021 @default.
- W3139129667 countsByYear W31391296672022 @default.
- W3139129667 crossrefType "journal-article" @default.
- W3139129667 hasAuthorship W3139129667A5001745874 @default.
- W3139129667 hasAuthorship W3139129667A5009870571 @default.
- W3139129667 hasAuthorship W3139129667A5014036986 @default.
- W3139129667 hasAuthorship W3139129667A5014585825 @default.